Lauri Jouhi

692 total citations
34 papers, 491 citations indexed

About

Lauri Jouhi is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Lauri Jouhi has authored 34 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Otorhinolaryngology, 13 papers in Surgery and 13 papers in Oncology. Recurrent topics in Lauri Jouhi's work include Head and Neck Cancer Studies (22 papers), Immune Response and Inflammation (7 papers) and Head and Neck Surgical Oncology (6 papers). Lauri Jouhi is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Immune Response and Inflammation (7 papers) and Head and Neck Surgical Oncology (6 papers). Lauri Jouhi collaborates with scholars based in Finland, Sweden and Libya. Lauri Jouhi's co-authors include Antti Mäkitie, Jaana Hagström, Caj Haglund, Timo Atula, Hesham Mohamed, Satu Maria Remes, Stina Syrjänen, Katri Aro, Leif Bäck and Petri S. Mattila and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Lauri Jouhi

33 papers receiving 487 citations

Peers

Lauri Jouhi
Lauri Jouhi
Citations per year, relative to Lauri Jouhi Lauri Jouhi (= 1×) peers Jérémy Augustin

Countries citing papers authored by Lauri Jouhi

Since Specialization
Citations

This map shows the geographic impact of Lauri Jouhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri Jouhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri Jouhi more than expected).

Fields of papers citing papers by Lauri Jouhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauri Jouhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri Jouhi. The network helps show where Lauri Jouhi may publish in the future.

Co-authorship network of co-authors of Lauri Jouhi

This figure shows the co-authorship network connecting the top 25 collaborators of Lauri Jouhi. A scholar is included among the top collaborators of Lauri Jouhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauri Jouhi. Lauri Jouhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almangush, Alhadi, Lauri Jouhi, Caj Haglund, et al.. (2023). Tumor-stroma ratio is a promising prognostic classifier in oropharyngeal cancer. Human Pathology. 136. 16–24. 10 indexed citations
2.
Almangush, Alhadi, Lauri Jouhi, Timo Atula, et al.. (2022). Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group. British Journal of Cancer. 126(11). 1589–1594. 29 indexed citations
3.
Sorsa, Timo, Lauri Jouhi, Harri Mustonen, et al.. (2022). Prognostic Role ofPorphyromonas gingivalisGingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma. Anticancer Research. 42(11). 5415–5430. 4 indexed citations
4.
Jouhi, Lauri, et al.. (2022). Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer. PLoS ONE. 17(9). e0274813–e0274813. 2 indexed citations
5.
Aro, Katri, et al.. (2021). Prognostic Value of Apparent Diffusion Coefficient in Oropharyngeal Carcinoma. Clinical Neuroradiology. 31(4). 1037–1048. 5 indexed citations
6.
Jouhi, Lauri, Hesham Mohamed, Antti Mäkitie, et al.. (2020). In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality. Oral Oncology. 107. 104778–104778. 3 indexed citations
7.
Haglund, Caj, Antti Mäkitie, Petri S. Mattila, et al.. (2020). Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. Experimental and Molecular Pathology. 114. 104435–104435. 5 indexed citations
8.
Syrjänen, Stina, Lauri Jouhi, Caj Haglund, et al.. (2020). Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. Cancer Immunology Immunotherapy. 69(8). 1615–1626. 24 indexed citations
9.
Mohamed, Hesham, Jaana Hagström, Lauri Jouhi, et al.. (2019). The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus–positive and –negative oropharyngeal squamous cell carcinoma. Tumor Biology. 41(3). 3726345647–3726345647. 4 indexed citations
10.
Sorsa, Timo, Lauri Jouhi, Taina Tervahartiala, et al.. (2019). High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer. Cancer Immunology Immunotherapy. 68(8). 1263–1272. 13 indexed citations
11.
Jouhi, Lauri, Timo Atula, Antti Mäkitie, & Harri Keski–Säntti. (2019). Management of clinically N0 neck in oropharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 276(4). 1205–1210. 5 indexed citations
12.
Mohamed, Hesham, Katri Aro, Lauri Jouhi, et al.. (2018). Expression of hormone receptors in oropharyngeal squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 275(5). 1289–1300. 11 indexed citations
13.
Vento, Seija, Lauri Jouhi, Hesham Mohamed, et al.. (2018). MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(6). 975–981. 7 indexed citations
14.
Jouhi, Lauri, Hesham Mohamed, Antti Mäkitie, et al.. (2018). Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma. British Journal of Cancer. 119(1). 89–95. 25 indexed citations
15.
Jouhi, Lauri, Timo Atula, Kauko Saarilahti, et al.. (2017). Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma. Head & Neck. 39(7). 1412–1420. 4 indexed citations
16.
Jouhi, Lauri, Hesham Mohamed, Antti Mäkitie, et al.. (2017). Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients. Cancer Immunology Immunotherapy. 66(12). 1619–1629. 33 indexed citations
17.
Bäck, Leif, Caj Haglund, Ilmo Leivo, et al.. (2016). Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands. Tumor Biology. 37(8). 10959–10964. 5 indexed citations
18.
Jouhi, Lauri, Neeta Datta, Timo Atula, et al.. (2015). Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma—an in vivo and in vitro study. Tumor Biology. 36(10). 7755–7764. 25 indexed citations
19.
Mäkinen, Laura K., Timo Atula, Valtteri Häyry, et al.. (2014). Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. Oral Oncology. 51(1). 96–102. 46 indexed citations
20.
Jouhi, Lauri, et al.. (2014). Different Toll-Like Receptor Expression Patterns in Progression toward Cancer. Frontiers in Immunology. 5. 638–638. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026